PHASE II STUDY OF LENALIDOMIDE IN COMBINATION WITH RITUXIMAB (R) FOR THE TREATMENT OF INDOLENT NON FOLLICULAR NON HODGKIN LYMPHOMA.
Phase of Trial: Phase II
Latest Information Update: 02 Aug 2016
At a glance
- Drugs Lenalidomide (Primary) ; Rituximab (Primary)
- Indications B cell lymphoma; Chronic lymphocytic leukaemia; Waldenstrom's macroglobulinaemia
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 09 Apr 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01830478).
- 09 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 30 Jul 2011 New trial record